Veterinary Medicines

XYLAZIN BIO 2%

Authorised
  • Xylazine hydrochloride
Download as PDF

Product identification

Medicine name:
XYLAZIN BIO 2%
Active substance:
  • Xylazine hydrochloride
Target species:
  • Cat
  • Cattle
  • Horse
  • Dog
Route of administration:
  • Subcutaneous use
  • Intravenous use
  • Intramuscular use

Product details

Active substance and strength:
  • Xylazine hydrochloride
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
  • Intravenous use
    • Cattle
      • Meat and offal
        1
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        1
        day
    • Dog
  • Intramuscular use
    • Cattle
      • Meat and offal
        1
        day
      • Milk
        0
        day
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CM92
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 150180
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 22/12/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."